GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Price-to-Funds-From-Operations

Femtobiomed (XKRX:327610) Price-to-Funds-From-Operations : (As of May. 04, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Femtobiomed Business Description

Industry
Traded in Other Exchanges
N/A
Address
17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.